Quest Diagnostics Incorporated (NYSE:DGX) will be hosting a conference call at 8:30 AM eastern time on 23rd July 2020, to discuss its 2Q20 financial results with the investment community.
A live webcast with presentations will be available on the Internet by visiting the Company website www.questdiagnostics.com
Earnings Expectation
Quest Diagnostics Incorporated medical laboratories diagnostic provider, is expected to report second quarter earnings results, before market open, on Thursday 23rd July 2020. Analysts polled by Thomson Reuters anticipate second quarter income of $ 1.40 per share. Looking ahead, the full year income are expected at $ 7.88 per share on the revenues of $ 8454.33 million.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 7,800.00 million ~ $ 7,960.00 million
Click Here For More Historical Outlooks Of Quest Diagnostics Incorporated
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic testing information and services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, Athena Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals.
